O'Connor W T, Leonard B E
Neuropharmacology. 1986 Mar;25(3):267-70. doi: 10.1016/0028-3908(86)90250-9.
Following its chronic administration, the racemic mianserin analogue of Org. 3770 attenuated the hypermotility of bilaterally olfactory-bulbectomized rats in the "open-field" apparatus, over the dose range of 0.5-2 mg/kg; only the largest dose of the drug was found to reduce the motility of the sham-operated animals. The activity of this compound would appear to reside in its S(+)isomer; the R(-)isomer being inactive. Bulbectomy was associated with a slight decrease in the concentration of noradrenaline and its major metabolite MHPG in the amygdaloid cortex and mid-brain. Following chronic administration of Org. 3770, the concentration of noradrenaline and MHPG returned to control levels. When the enantiomers were tested, it was found that the behaviourally-inactive R(-)isomer was most effective in normalizing the deficit in this neurotransmitter. Thus, no correlation could be found between the behavioural activity of the enantiomers of Org. 3770 and changes in the metabolism of noradrenaline in the amygdaloid cortex and mid-brain.
长期给药后,Org. 3770的外消旋米安色林类似物在0.5 - 2毫克/千克的剂量范围内,可减轻双侧嗅球切除大鼠在“旷场”实验装置中的运动亢进;仅发现最大剂量的该药物会降低假手术动物的运动性。该化合物的活性似乎存在于其S(+)异构体中;R(-)异构体无活性。嗅球切除与杏仁核皮质和中脑中去甲肾上腺素及其主要代谢产物MHPG的浓度略有降低有关。长期给予Org. 3770后,去甲肾上腺素和MHPG的浓度恢复到对照水平。当测试对映体时,发现行为上无活性的R(-)异构体在使这种神经递质的缺乏正常化方面最有效。因此,在Org. 3770对映体的行为活性与杏仁核皮质和中脑中去甲肾上腺素代谢变化之间未发现相关性。